RNA Splicing by the Spliceosome.


Journal

Annual review of biochemistry
ISSN: 1545-4509
Titre abrégé: Annu Rev Biochem
Pays: United States
ID NLM: 2985150R

Informations de publication

Date de publication:
20 06 2020
Historique:
pubmed: 4 12 2019
medline: 2 6 2021
entrez: 4 12 2019
Statut: ppublish

Résumé

The spliceosome removes introns from messenger RNA precursors (pre-mRNA). Decades of biochemistry and genetics combined with recent structural studies of the spliceosome have produced a detailed view of the mechanism of splicing. In this review, we aim to make this mechanism understandable and provide several videos of the spliceosome in action to illustrate the intricate choreography of splicing. The U1 and U2 small nuclear ribonucleoproteins (snRNPs) mark an intron and recruit the U4/U6.U5 tri-snRNP. Transfer of the 5' splice site (5'SS) from U1 to U6 snRNA triggers unwinding of U6 snRNA from U4 snRNA. U6 folds with U2 snRNA into an RNA-based active site that positions the 5'SS at two catalytic metal ions. The branch point (BP) adenosine attacks the 5'SS, producing a free 5' exon. Removal of the BP adenosine from the active site allows the 3'SS to bind, so that the 5' exon attacks the 3'SS to produce mature mRNA and an excised lariat intron.

Identifiants

pubmed: 31794245
doi: 10.1146/annurev-biochem-091719-064225
doi:

Substances chimiques

RNA Precursors 0
RNA Splicing Factors 0
RNA, Small Nuclear 0
Saccharomyces cerevisiae Proteins 0
DDX23 protein, human EC 2.7.7.-
PRP28 protein, S cerevisiae EC 3.6.1.-
DEAD-box RNA Helicases EC 3.6.4.13
RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

359-388

Subventions

Organisme : Medical Research Council
ID : MC_U105184330
Pays : United Kingdom

Auteurs

Max E Wilkinson (ME)

MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom; email: mwilkin@mrc-lmb.cam.ac.uk, ccharent@mrc-lmb.cam.ac.uk.

Clément Charenton (C)

MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom; email: mwilkin@mrc-lmb.cam.ac.uk, ccharent@mrc-lmb.cam.ac.uk.

Kiyoshi Nagai (K)

MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom; email: mwilkin@mrc-lmb.cam.ac.uk, ccharent@mrc-lmb.cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH